Hill October 3, 2023
All 10 manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said Tuesday, even as many of them are currently suing the administration in an effort to halt the process.
Many of the companies told The Hill separately ahead of the Oct. 1 deadline that they would participate. The White House confirmed the news in an announcement, taking a political victory lap.
Last year, about 9 million Medicare enrollees spent $3.4 billion out of pocket on the selected drugs from companies, including Johnson & Johnson, Merck, Bristol Myers Squibb and AstraZeneca, the White House said.
“For decades, Big Pharma fought to block Medicare from directly negotiating lower drug prices for seniors and other...
Today's Sponsors
Today's Sponsor